Determination of nine prostaglandins in the arachidonic acid metabolic pathway with UHPLC-QQQ-MS/MS and application to in vitro and in vivo inflammation models.

阅读:4
作者:Huang Yufeng, Wang Mengxian, Yang Ziqi, Wang Xiaotong, Wang Xinxin, He Fan
BACKGROUND: Prostaglandins play a vital role as crucial metabolites and inflammatory indicators within the arachidonic acid (AA) metabolic pathway. Conventional assays typically focus on a single inflammatory indicator, while multi-index detection entails a large number of samples. METHODS: In this study, an ultra-high-performance liquid chromatography coupled with triple quadrupole mass spectrometry (UHPLC-QQQ-MS/MS) method was newly developed for simultaneous quantitative analysis of nine AA metabolites, including prostaglandin F2β (PGF(2β)), prostaglandin E2 (PGE(2)), prostaglandin E1 (PGE(1)), prostaglandin D1 (PGD(1)), prostaglandin D2 (PGD(2)), prostaglandin A2 (PGA(2)), prostaglandin J2 (PGJ(2)), prostaglandin B2 (PGB(2)), and prostaglandin A1 (PGA(1)), in the supernatant of LPS-induced RAW264.7 cells and the serum samples of adjuvant-induced arthritis (AIA) rats. RESULTS: The newly established UHPLC-QQQ-MS/MS method successfully and rapidly quantified the contents of the nine prostaglandins simultaneously. The methodology was validated. The levels of PGE(2), PGD(1), PGD(2), PGA(2), and PGJ(2) in the LPS-induced RAW264.7 cells group were higher than those in blank group. At the same time, the levels of these PGs decreased significantly (p < 0.01 vs. LPS-induced group) after the positive drug (dexamethasone) intervention. On the 14th day of AIA modeling, the paw volume of the AIA rats was significantly enlarged (p < 0.01 vs. blank group), and the serum samples from the AIA group showed significantly increased levels of PGE(2), PGD(2), and PGA(2) (p < 0.01 vs. blank group), suggesting the emergence of arthritis. The levels of other prostaglandins were below the limit of quantification. CONCLUSION: The method established in this study for determining nine prostaglandins in the AA metabolic pathway with UHPLC-QQQ-MS/MS embodied the advantages of requiring a low amount of sample, a simple pretreatment process, and the rapid and efficient simultaneous quantification of multiple inflammatory factors. It provided a novel assay method for the pharmacological study of the AA metabolic pathway.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。